Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis

作者: R Karim , Sykakis , Sue Lightman , Fraserbell

DOI: 10.2147/OPTH.S40268

关键词:

摘要: Background Uveitic macular edema is the major cause of reduced vision in eyes with uveitis. Objectives To assess effectiveness interventions treatment uveitic edema. Search strategy Cochrane Central Register Controlled Trials, Medline, and Embase. There were no language or data restrictions search for trials. The databases last searched on December 1, 2011. Reference lists included trials searched. Archives Ophthalmology, Retina, British Journal New England Medicine clinical reviews. Selection criteria Participants any age sex type included. Early, chronic, refractory, secondary We that compared dose duration, including comparison another treatment, sham treatment. Data collection analysis Best-corrected visual acuity central thickness primary outcome measures. Secondary adverse effects collected. Conclusion More results from randomized controlled long follow-up periods are needed to assist determining overall long-term benefit different treatments. only intervention sufficiently robust a meta-analysis was acetazolamide, which shown be ineffective improving edema, clinically now rarely used. Interventions showing promise this disease include dexamethasone implants, immunomodulatory drugs anti-vascular endothelial growth-factor agents. When has become refractory after multiple interventions, pars plana vitrectomy could considered. pathophysiology uncertain course unpredictable. As there clear guidelines literature, should tailored individual patient.

参考文章(106)
Masoud Soheilian, Zahra Rabbanikhah, Alireza Ramezani, Victoria Kiavash, Mehdi Yaseri, Gholam A. Peyman, Intravitreal Bevacizumab Versus Triamcinolone Acetonide for Refractory Uveitic Cystoid Macular Edema: A Randomized Pilot Study Journal of Ocular Pharmacology and Therapeutics. ,vol. 26, pp. 199- 206 ,(2010) , 10.1089/JOP.2009.0093
Jianmin Wang, Mohamed Ibrahim, Peykan Turkcuoglu, Elham Hatef, Afsheen Khwaja, Roomasa Channa, Diana V. Do, Quan Dong Nguyen, Intercellular adhesion molecule inhibitors as potential therapy for refractory uveitic macular edema Ocular Immunology and Inflammation. ,vol. 18, pp. 395- 398 ,(2010) , 10.3109/09273948.2010.483317
Annette Ossewaarde-van Norel, Aniki Rothova, Clinical Review: Update on Treatment of Inflammatory Macular Edema Ocular Immunology and Inflammation. ,vol. 19, pp. 75- 83 ,(2011) , 10.3109/09273948.2010.509530
Douglas A. Jabs, James T. Rosenbaum, C.Stephen Foster, Gary N. Holland, Glenn J. Jaffe, James S. Louie, Robert B. Nussenblatt, E.Richard Stiehm, Howard Tessler, Russell N. Van Gelder, Scott M. Whitcup, David Yocum, Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel American Journal of Ophthalmology. ,vol. 130, pp. 492- 513 ,(2000) , 10.1016/S0002-9394(00)00659-0
Carsten H. Meyer, Stephan Michels, Eduardo B. Rodrigues, Annette Hager, Stefan Mennel, Jörg C. Schmidt, Hans-Martin Helb, Michel E. Farah, Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections Acta Ophthalmologica. ,vol. 89, pp. 70- 75 ,(2011) , 10.1111/J.1755-3768.2010.02064.X
Sapna Gangaputra, Craig W Newcomb, Teresa L Liesegang, R Oktay Kaçmaz, Douglas A Jabs, Grace A Levy-Clarke, Robert B Nussenblatt, James T Rosenbaum, Eric B Suhler, Jennifer E Thorne, C Stephen Foster, John H Kempen, Methotrexate for Ocular Inflammatory Diseases Ophthalmology. ,vol. 116, pp. 2188- 2198 ,(2009) , 10.1016/J.OPHTHA.2009.04.020
P Y Chang, G P Giuliari, M Shaikh, P Thakuria, D Makhoul, C S Foster, Mycophenolate mofetil monotherapy in the management of paediatric uveitis Eye. ,vol. 25, pp. 427- 435 ,(2011) , 10.1038/EYE.2011.23
N. Gulati, F. Forooghian, R. Lieberman, D. A. Jabs, Vascular endothelial growth factor inhibition in uveitis: a systematic review British Journal of Ophthalmology. ,vol. 95, pp. 162- 165 ,(2011) , 10.1136/BJO.2009.177279
Ahmad Mirshahi, Abed Namavari, Ali Djalilian, Yashar Moharamzad, Hormoz Chams, Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behçet disease. Ocular Immunology and Inflammation. ,vol. 17, pp. 59- 64 ,(2009) , 10.1080/09273940802553295